Innospec stock gains on stronger earnings outlook and year-to-date rally

Published on 09/17/2026 at 18:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Innospec stock is up 21.4% year-to-date as of September 17, 2026, supported by an improving earnings outlook and a Zacks Rank 2 rating. Consensus now pegs current-year EPS at 5.03 dollars, implying a 4.55 percent decline from last year but with upgrades in recent months.

IOSP, US45768S1033, Illustration mit AI erstellt.

Innospec Inc. stock (ISIN US45768S1033) has delivered a notable run in 2026, with the shares up 21.4 percent year-to-date as of September 17, 2026, according to Yahoo Finance.

Consensus earnings signal a modest decline

For the current fiscal year, the Zacks Consensus Estimate for Innospec's earnings stands at 5.03 dollars per share, implying a 4.55 percent decrease versus the prior year, according to Zacks.

The same consensus figure of 5.03 dollars per share and the 4.55 percent expected earnings decline are reiterated in another overview, with Zacks highlighting that Innospec has beaten consensus estimates in each of the trailing four quarters and delivered an average earnings surprise of 12.9 percent, as noted by Zacks.

Zacks Rank 2 and dividend support the case

Analysts at Zacks currently assign Innospec stock a Zacks Rank 2 rating (Buy), reflecting positive relative momentum and earnings revisions compared with other basic materials names, as reported by Yahoo Finance.

In addition to the earnings outlook, Innospec offers income to shareholders through an annual dividend of 1.84 dollars per share, which translates into a dividend yield of roughly 2.0 percent at recent price levels, according to MarketBeat.

Valuation view and technical backdrop

From a quantitative valuation perspective, one screening tool rates Innospec with a strong quality and value profile, assigning the shares a rating of A with a fair value estimate of 92.93 dollars and a buy-below level of 103.65 dollars, implying about 12 percent upside to the buy-below threshold from the fair value, per Kabrios.

On the technical front, peer comparisons place Innospec among specialty chemicals names such as Huntsman and Minerals Technologies, with Innospec distinguished by its combination of total return and dividend yield, as outlined in the competitors overview on MarketBeat.

Stock price and market data

As of the most recent completed trading session ahead of September 17, 2026, Innospec shares traded on their primary listing in the United States at around the low-90s dollar range on the Nasdaq exchange, with the year-to-date increase of 21.4 percent placing the stock comfortably above levels seen at the start of 2026, according to performance data cited by Yahoo Finance.